🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the efficacy and side effects of d...
Status
Unknown
Location
Hematology-Oncology & SCT Research Center
Start Date
2009-09
Trial ID
NCT01238328
Treatments Being Tested
This study proposes the use of a reduced intensity chemotherapy/radiation t...
Status
Completed
Location
Columbia University Medical Center
Start Date
2002-09
Trial ID
NCT01019876
The purpose of this study is to examine the toxicity of using allogeneic st...
Status
Completed
Location
University of Louisville
Start Date
2013-04
Trial ID
NCT02472392
Treatments Being Tested
The purpose of this study is to determine the safety and toxicity and feasi...
Status
Terminated
Location
Columbia Presbyterian Medical Center
Start Date
2007-09-06
Trial ID
NCT00801931
Background: Blood stem cells in the bone marrow make all the cells to norm...
Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2018-09-04
Trial ID
NCT03663933
The purpose of this study is to evaluate the efficacy and side effects of d...
Status
Unknown
Location
Hematology-Oncology & SCT Research Center
Start Date
2009-09
Trial ID
NCT01087398
This is an open-label, single institution, phase II study in patients with ...
Status
Completed
Location
University of Minnesota Masonic Cancer Center and Medical Center
Start Date
2010-01
Trial ID
NCT01033552
The purpose of this study is to develop a standard of care treatment using ...
Status
Terminated
Location
Masonic Cancer Center, University of Minnesota
Start Date
2001-10
Trial ID
NCT00176930
This protocol studied the effect of administration of a myeloablative pretr...
Status
Completed
Location
St. Jude Children's Research Hospital
Start Date
1992-12
Trial ID
NCT00186810
Treatments Being Tested
Background: \- GATA2 deficiency is a disease caused by mutations in the GA...
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2013-07-24
Trial ID
NCT01861106